EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti-Diabetic Drugs Inhibit Bulimia Induced Obesity

Zhu Li, Jia Jia, Han Hao, Shiyang Qiao, Qinglei Zhang, Xinlin Zhang, Yu Qi, Xuan Sun, Kun Wang, Rong Gu, Lina Kang, Biao Xu

Frontiers in Bioscience-Landmark · 2023

DOI: 10.31083/j.fbl2805097 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2023. Verfasst von Zhu Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Affiliated Drum Tower Hospital, Medical School, Nanjing University, 210008 Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Bulimia, Metformin, Diabetes Mellitus, Type 2. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of China, Key Project supported by Medical Science and Technology Development Foundation, Nanjing Department of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Obesity is primarily a consequence of food addiction. Drugs have been confirmed effective for weight loss more or less related to the functional connectivity in neural networks and metabolic patterns. Recent studies have shown that some anti-diabetic drugs, such as Metformin and Dapagliflozin have similar weight loss effects, however, their mechanisms are unclear. We hypothesized that the functional connectivity and energy metabolism might be associated with the mechanisms.

Methods

Male ob/ob mice were fed with high-fructose-fat-diet (HFFD) for 4 weeks to esteblish obesity model. Then mice were divided into normal saline (NS, as control), Metformin (Metformin, 50 mg/kg/day by gavage), and Dapagliflozin (Dapagliflozin, 10 mg/kg/day by gavage) groups. Functional connectivity amplitude of low-frequency signal fluctuations and regional cerebral blood volume (rCBV) quantification were statistically analyzed in the linear mixed model, meanwhile, metabolic pattern of intestinal cells (IECs) were also tested.

Results

Our results showed that Blood Oxygen on Level Depending (Bold) signaling responses, functional connectivity, and rCBV quantification tended to be attenuated in the Metformin group compared to the control and Dapagliflozin groups. While only Dapagliflozin prevented HFFD induced hyper survival of intestinal cells and hypertrophy of intestinal villus by reducing glycolysis levels. Both Metformin and Dapagliflozin are effective for weight loss.

Conclusions

Our findings showed that Dapagliflozin and Metformin may inhibit bulimia induced obesity with different mechanisms. We speculate that Metformin may affect appetite regulation, while Dapagliflozin can affect the survival and metabolic patterns of intestinal cells, thus significantly affecting the absorption of nutrients. So, combining Metformin and Dapgliflozin may be more beneficial for clinical improvement in bulimia induced obesity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BulimiaMetforminDiabetes Mellitus, Type 2MaleMiceAnimalsObesityWeight LossHypoglycemic AgentsDrug Therapy, CombinationBenzhydryl CompoundsGlucosides

Stichwörter der Autor:innen

DapagliflozinMetforminintestinal villusmetabolic patternsneural networksobesity

Substanzen

MetforminHypoglycemic AgentsdapagliflozinBenzhydryl CompoundsGlucosides

Autor:innen und Institutionen

  • Department of Cardiology, Affiliated Drum Tower Hospital, Medical School, Nanjing University, 210008 Nanjing, Jiangsu, China.
  • Department of Medical Laboratory, Affiliated Drum Tower Hospital, Medical School, Nanjing University, 210008 Nanjing, Jiangsu, China.
  • Department of Medical Imaging, Affiliated Drum Tower Hospital, Medical School, Nanjing University, 210008 Nanjing, Jiangsu, China.

Förderung

  • Natural Science Foundation of China
  • Key Project supported by Medical Science and Technology Development Foundation, Nanjing Department of Health

Zitieren

APA

Li, Z., Jia, J., Hao, H., Qiao, S., Zhang, Q., Zhang, X., Qi, Y., Sun, X., Wang, K., Gu, R., Kang, L., & Xu, B. (2023). Anti-Diabetic Drugs Inhibit Bulimia Induced Obesity. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2805097

Vancouver

Li Z, Jia J, Hao H, Qiao S, Zhang Q, Zhang X, et al. Anti-Diabetic Drugs Inhibit Bulimia Induced Obesity. Frontiers in Bioscience-Landmark. 2023. doi:10.31083/j.fbl2805097

BibTeX
@article{Li2023,
  author = {Li, Zhu and Jia, Jia and Hao, Han and Qiao, Shiyang and Zhang, Qinglei and Zhang, Xinlin and Qi, Yu and Sun, Xuan and Wang, Kun and Gu, Rong and Kang, Lina and Xu, Biao},
  title = {Anti-Diabetic Drugs Inhibit Bulimia Induced Obesity},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2023},
  doi = {10.31083/j.fbl2805097}
}
Kostenlos starten →